SEC Form 4 · accession 0001209191-15-076450
STERIS CORP · STE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel A Carestio
Officer — Sr. V. P., Isomedix & Life Sci
Period of report
Oct 20, 2015
Accepted (ET)
Oct 22, 2015 · 4:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000815065
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares, No Par ValueF2,F3 | Oct 20, 2015 | S | 881 | $68.2522 | D | 23,070 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction involved the open market sale on October 20, 2015 of a total of 881 shares, held by the Reporting Person, pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person, effective June 11, 2015.
- F2This represents the average sales price of the 881 shares sold in the open market. The actual six sales prices ranged from $68.00 per share to $68.62 per share. Issuer, upon request by the SEC staff, will provide full information regarding the number of shares sold at each of these six sales prices.
- F316,800 of these Common Shares are restricted. The restrictions on these Common Shares lapse as follows: 4,500 on May 31, 2016; 3,300 on May 31, 2017; 4,000 on May 30, 2018; and 5,000 on May 28, 2019.